Consequently, improvements in antioxidant defenses and reduced oxidative stress and inflammation were attributed to Nrf2, PPARγ, and SIRT1 activation in the heart of CIS-administered rats treated with OCA and EDV. Here, PPARG is linked to in situ carcinoma.